Company to Participate in Upcoming Conferences WASHINGTON , Oct. 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may... Read More

Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path. Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to Evolent's free cash flow by more than $7 million per year. Evolent reiterates outlook for Q3 2025 and full year 2025 for Revenue and Adjusted EBITDA, excluding the effect of the transaction. WASHINGTON , Sept. 23, 2025... Read More

WASHINGTON , Aug. 19, 2025 /PRNewswire/ -- Evolent Health, Inc . (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced the pricing of $145.0 million aggregate principal amount of 4.50% convertible senior notes due 2031. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under... Read More

WASHINGTON , Aug. 18, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) , a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that it intends to offer $140.0 million aggregate principal amount of convertible senior notes due 2031, subject to market and other conditions. Evolent also expects to grant the initial purchasers in the proposed offering an option... Read More

WASHINGTON , Aug. 7, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended June 30, 2025. Seth Blackley , Co-Founder and Chief Executive Officer of Evolent stated, "Evolent... Read More

Company to Participate in Upcoming Conferences WASHINGTON , July 14, 2025 /PRNewswire/ - - Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2025 financial results on Thursday, August 7, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants... Read More

Dr. David Lim joins Evolent as chief clinical officer John Way joins Evolent as CFO, Performance Suite WASHINGTON , July 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced leadership additions to its clinical and financial teams, as it continues to drive innovation in specialty care. Physician, executive and... Read More

Notes accelerating 2026 revenue bookings forecast Secures incremental non-dilutive financing WASHINGTON , June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that based on leading indicators and paid claims data through May, it continues to experience oncology cost trend below expectations coming into 2025.... Read More

WASHINGTON , May 8, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2025. Seth Blackley , Co-Founder and Chief Executive Officer of Evolent stated, "Evolent... Read More

Former CFO of CVS Health, Aetna and Coventry Health Care brings deep experience driving growth and profitability. Mr. Guertin's nomination represents continuation of Evolent's board refreshment efforts. WASHINGTON , April 22, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced that a new director nominee... Read More

Program aims to achieve the best possible treatment outcomes — longer lives with fewer side-effects — without excess financial strain. Collegial provider engagement model brings together education, technology and incentives to encourage top-quality regimens. One low-value regimen costs about 70 times more than a clinically equivalent alternative. WASHINGTON , April 15, 2025 /PRNewswire/ -- When treating patients with cancer,... Read More

Company to Participate in Upcoming Conferences WASHINGTON , April 10, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may... Read More

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN FRANCISCO , March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill , former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of... Read More

Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024 , representing 16.3% and 30.1% growth over 2023, respectively. Net loss attributable to common shareholders of Evolent Health, Inc. of $30.6 million for three months ended December 31, 2024 and $93.5 million for the year ended December 31, 2024 , resulting in a net loss margin of (4.7)% and (3.7)%,... Read More

Richard "Rick" Jelinek to Be Named Chair of the Board at 2025 Annual Meeting Company Continues Board Refreshment Efforts with Brendan Springstubb 's Appointment as New Independent Director WASHINGTON , Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to its Board of Directors as part of... Read More

Company to Participate in Upcoming Conferences WASHINGTON , Jan. 27, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its fourth quarter 2024 financial results on Thursday, February 20, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants... Read More

Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus. WASHINGTON , Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025 . Dr. Nguyen joined Evolent as Chief Clinical Officer in July 2024 after serving as... Read More

Partnership Focuses on Improving Prior Authorization Process, Helping Drive Better Patient Outcomes WASHINGTON / Nov 07, 2024 / Business Wire / Humana Inc. (NYSE: HUM) and Evolent Health, Inc. (NYSE: EVH) announced they have expanded their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services. By connecting all primary approaches... Read More

Revenue of $621.4 million , an increase of $110.4 million or 21.6%, from the three months ended September 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) million and a net loss margin of (5.0)%. Adjusted EBITDA of $31.8 million resulting in an Adjusted EBITDA margin of 5.1%. Revises outlook for Adjusted EBITDA for 2024. Reiterates average annual long-term revenue and average... Read More

The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation SAN FRANCISCO , Oct. 22, 2024 /PRNewswire/ -- Define Ventures , one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard , former CEO and president of Humana (NYSE: HUM), has joined the firm as venture partner. Bruce will play a... Read More

Company to Participate in Upcoming Conferences WASHINGTON , Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2024 financial results on Thursday, November 7, 2024, after market close, with a... Read More

Revenue of $647.1 million , an increase of $178.0 million or 37.9%, from the three months ended June 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and a net loss margin of (1.0)%. Adjusted EBITDA of $52.0 million resulting in an Adjusted EBITDA margin of 8.0%. Narrows revenue outlook for full year 2024 and provides updated 2024 Adjusted EBITDA guidance. Reiterates... Read More

Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after market close, with a conference... Read More

Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automation Machinify technology leverages the latest advances in applied machine learning, large language models and data analytics Acquisition expected to benefit health plans, clinicians, and members WASHINGTON , June 4, 2024 /PRNewswire/ -- Evolent... Read More

Digital cancer care platform Careology and Evolent (NYSE: EVH) to offer an innovative platform to enable cancer navigation Evolent will embed Careology's digital cancer care technology within its comprehensive care navigation services offered to health plan clients across the U.S. WASHINGTON , May 9, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a $2 billion revenue company focused on achieving better health... Read More

Revenue of $639.7 million , an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million and a net loss margin of (3.9)%. Adjusted EBITDA of $54.1 million resulting in an Adjusted EBITDA margin of 8.5%. Raises revenue outlook for full year 2024 and reiterates full year 2024 Adjusted EBITDA guidance. WASHINGTON ,... Read More

Company to Participate in Upcoming Conferences WASHINGTON , April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable, today announced it will release its first quarter 2024 financial results on Thursday, May 9, 2024 , after market close, with a conference... Read More

WASHINGTON , Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months and year ended December 31, 2023. Seth Blackley , Chief Executive Officer, and Co-Founder of Evolent stated, "We ended 2023 on a... Read More

WASHINGTON , Feb. 14, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today appointed Russell Glass to its Board of Directors. Glass has almost 25 years of experience as a successful technology and health care executive who currently serves as Chief... Read More

Company to Participate in Upcoming Investor Conferences WASHINGTON , Jan. 25, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its fourth quarter 2023 financial results on Thursday, Feb. 22, 2024, after market close, with a... Read More

WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced the pricing of $350.0 million aggregate principal amount of 3.50% convertible senior notes due 2029. The notes are being offered only to persons reasonably... Read More

WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced that it intends to offer $350.0 million aggregate principal amount of convertible senior notes due 2029, subject to market and other conditions. Evolent also... Read More

WASHINGTON , Nov. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended September 30, 2023. Highlights from the third quarter 2023 announcement include: Revenue of $511.0 million , an increase of $158.4... Read More

WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2023 financial results on Thursday, Nov. 2, 2023 , after market close, with a conference call to follow at 5 p.m. ET. Shareholders and... Read More

Company also confirms launch date of Performance Suite partnership with Humana in North Florida WASHINGTON , Aug. 24, 2023 /PRNewswire/ -- Evolent Health, Inc. ( NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced today that its accountable care organization (ACO) saved Medicare more than $55... Read More

WASHINGTON , Aug. 8, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced that Chief Executive Officer Seth Blackley , Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor... Read More

WASHINGTON , Aug. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended June 30, 2023 . Highlights from the second quarter 2023 announcement include: Revenue of $469.1 million , an increase of $149.2... Read More

Dr. Ajayi becomes the ninth independent board member; adds exceptional, relevant expertise as a CEO, physician, entrepreneur and advocate for improving health care quality and cost for underserved populations. WASHINGTON , July 26, 2023 /PRNewswire/ -- Evolent Health Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced today that its Board of... Read More

WASHINGTON , July 13, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced today that it will release its second quarter 2023 financial results on Wednesday, August 2, 2023 , after market close, with a conference call to follow at 5 p.m. ET . Shareholders and interested participants may listen to a live... Read More

Growth-focused company is a trusted partner for health plans and providers seeking to improve health outcomes across complex conditions. WASHINGTON , July 11, 2023 /PRNewswire/ -- Evolent Health ("the Company") (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced today that it is rebranding as Evolent and will integrate its portfolio of solutions and... Read More

WASHINGTON , May 9, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley , Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors... Read More

WASHINGTON , May 3, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2023. Highlights from the first quarter 2023 announcement include: Revenue of $427.7 million , an increase of $130.6 million , or 44.0%, from the three months ended March 31, 2022.... Read More

Richard Jelinek nominated to join the Board; current director David Farner to depart the Board in June 2023 , in addition to previously announced departure of Frank Williams . WASHINGTON , April 19, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced that a new director nominee will stand for election to the... Read More

Company to Also Host an Investor Day on Tuesday, May 23 WASHINGTON , April 17, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced it will release its first quarter 2023 financial results on Wednesday, May 3, 2023 , after market close, with a conference call to follow at 5 p.m. ET . Shareholders and interested... Read More

WASHINGTON , March 29, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, today announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation, (NYSE: CNC). Centene will expand its use of Evolent Health's oncology solution across its Centene and... Read More

WASHINGTON , March 3, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations, Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations. A live audio-only... Read More

WASHINGTON , Nov. 29, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley , Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences. A live audio-only webcast and replay for these... Read More